Showing 341-350 of 354 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Phase II Study of Oral HLA DQ8 Inhibitor in Adults with Type-I Diabetes | Aurimi Therapeutics | Nandan Padukone | Cures | 01-September-2026 to 31-August-2030 | $1.900.000,00 |
| Oxygen Enabled High-capacity Vascularized Devices for ß-cell Replacement Therapy in Humans | Arizona Board of Regents, University of Arizona | Klearchos Papas | Cures | 01-September-2023 to 31-May-2027 | $2.852.490,70 |
| Towards non-invasive imaging and improvement of islet engraftment via vascularization and oxygenation | Arizona Board of Regents, University of Arizona | Klearchos Papas | Cures | 01-October-2025 to 30-September-2027 | $897.151,29 |
| In vivo validation and translational development of minimally immunogenic beta cells | Arizona Board of Regents, University of Arizona | Deepta Bhattacharya | Cures | 01-May-2026 to 30-April-2028 | $698.423,87 |
| Deciphering the logic of genetic variant interactions in autoimmunity | Arc Insitute | Maya Arce | Cures | 01-September-2026 to 31-August-2027 | $148.614,38 |
| A hybrid effectiveness implementation trial of an intervention to reduce diabetes-specific emotional distress. | Ann & Robert H. Lurie Children’s Hospital of Chicago | Jill Weissberg-Benchell | Improving Lives | 01-September-2024 to 31-August-2029 | $567.017,00 |
| Evaluating the Initial Efficacy, Acceptability, and Feasibility of BFST-DT, an Intervention for Improving Transition Readiness for Adolescents and Emerging Adults with Type 1 Diabetes | Ann & Robert H. Lurie Children’s Hospital of Chicago | Jaclyn Papadakis | Improving Lives | 01-May-2023 to 30-April-2027 | $396.471,68 |
| Telemedicine-Delivered Cognitive Behavioral Therapy to Reduce Diabetes Distress in Young Adults with Type 1 Diabetes (CBT-DD) | Albert Einstein College of Medicine | Jeffrey Gonzalez | Improving Lives | 01-September-2021 to 30-June-2027 | $1.870.600,00 |
| Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression in Young Adults with Type 1 Diabetes | Albert Einstein College of Medicine | Jeffrey Gonzalez | Improving Lives | 01-December-2022 to 30-November-2026 | $1.672.180,00 |
| Localized Immunosuppressive Antibody Therapy for Enhancing Islet Graft Survival in Type 1 Diabetes | Aeterna Therapeutics | Maria Kondratyev | Cures | 01-May-2026 to 28-February-2027 | $200.000,00 |